Malignant lymphoma sometimes involves peripheral nerves due to paraneoplastic syndrome associated with anti-ganglioside antibodies. We report a very rare case of malignant lymphoma accompanied by an asymmetrical and isolated hypoglossal nerve palsy associated with a new subset of anti-ganglioside antibodies. Magnetic resonance imaging and 18 F-2-deoxy-2-fluoro-D-glucose position emission tomography showed no abnormalities of the hypoglossal nerve nucleus; however, the patient's serum was positive for anti-sulfated glucuronyl paragloboside IgM antibodies as well as anti-GM1 IgM and anti-GQ1b IgM antibodies. The present case might suggest a paraneoplastic asymmetrical and isolated hypoglossal nerve palsy associated with a new subset of anti-ganglioside antibodies.
Introduction
Malignant lymphoma mainly involves the peripheral nerves due to the direct invasion of malignant cells, and sometimes due to paraneoplastic syndrome associated with anti-ganglioside antibodies (1) . However, to the best of our knowledge there have been no reported cases of lymphoma presenting with hypoglossal nerve palsy with antiganglioside antibodies. Among the five previously reported cases of asymmetrical hypoglossal nerve palsy with positive anti-ganglioside antibodies, including anti-GM1 and antiGD1b antibodies, only one case involved an asymmetrical and isolated hypoglossal nerve palsy (Table) (2) (3) (4) (5) (6) . We herein report a very rare case of malignant lymphoma presenting with an asymmetrical and isolated hypoglossal nerve palsy due to paraneoplastic syndrome associated with a new subset of anti-ganglioside antibodies.
Case Report
A 75-year-old man consulted a nearby clinic due to mild dysarthria without advanced infections (i.e., diarrhea); however, a subsequent brain MRI revealed no abnormalities. In the 3 months that followed he developed a persistent fever of 38 , night sweats, and body weight loss (4 kg). Subsequently he showed severe dysarthria and his tongue deviated to the right on protrusion. He was admitted to our hospital for further examination at 4 months after the onset of symptoms.
On admission to our hospital, neurological examinations showed severe dysarthria, right-dominant atrophy and weak- A nerve conduction study (NCS) revealed no abnormal findings in the median, tibial and sural nerves. Gadolinium (Gd)-enhanced T1-weighted brain magnetic resonance imaging (MRI) revealed abnormalities of the hypoglossal nerve or hypoglossal nerve nucleus in the medulla oblongata (Figure b, arrows) . Whole body computed tomography (CT) showed only mild splenomegaly. 18F-2-deoxy-2-fluoro-Dglucose (FDG)-positron emission tomography (PET)-CT revealed hot spots on the left side of the oropharynx (Figure d, arrow) , spleen (Figure c, f, arrowheads) , and generalized bone marrow (Figure c, arrows) , but no abnormalities of the hypoglossal nerve nucleus in the medulla oblongata (Figure e) . A bone marrow biopsy showed only hypercellular bone marrow with aggregated CD20-positive B-cells without immunoglobulin light chain restriction, and with no evidence of malignancy. In contrast, a left tonsil biopsy specimen showed the proliferation of large round atypical lymphocytes (Figure g ) that were negative for CD3 (Figure h) and positive for CD20 (Figure i) and Ki-67 (Fig-Figure. (g-j) The pathological examination of a left tonsil biopsy specimen revealed the proliferation of large round atypical lymphocytes (g) that were negative for CD3 (h) and positive for CD20 (i) and Ki-67 (j). ure j), which led to a diagnosis of diffuse large B cell lymphoma (DLBCL). A test of the patient's serum for antiganglioside antibodies was strongly positive (3+) for anti-GM1 IgM, and mildly positive (1+) for anti-GQ1b IgM and anti-sulfated glucuronyl paragloboside (SGPG) IgM antibodies.
Based on the above findings, we suspected that the bilateral hypoglossal nerve palsy was caused by a paraneoplastic syndrome related to malignant lymphoma, but with no direct invasion of the malignancy. Thus the patient was treated with cyclophosphamide (900 mg), doxorubicin (60 mg), vincristine (1.6 mg), and prednisolone (70 mg for 5 days). However, his tongue symptom did not improve, and he died of Pneumocystis pneumonia after 2 weeks of chemotherapy.
Discussion
The present case showed an isolated hypoglossal nerve palsy (R>>L, Figure a) without other neurological findings, accompanied by DLBCL. Gd-enhanced brain MRI and FDG-PET-CT showed no abnormalities of the hypoglossal nerve nucleus (Figure b and e) , but a test of his serum for anti-ganglioside antibodies was positive for anti-GM1 IgM, anti-GQ1b IgM and anti-SGPG IgM antibodies. He had DM, but the neurological findings and NCS revealed no abnormal findings in relation to the motor, sensory or autonomic systems. To the best of our knowledge there have been no reported cases of DM presenting with an isolated hypoglossal nerve palsy. Thus, a paraneoplastic syndrome related to malignant lymphoma, but without the direct invasion of the malignancy, was suspected in the present case.
The peripheral neuropathy observed in lymphoma is mainly due to the direct invasion of malignant cells, and sometimes due to a paraneoplastic syndrome associated with anti-ganglioside antibodies (1) . Previous reports have shown five cases of asymmetrical hypoglossal nerve palsy in patients without malignancy who were positive for antiganglioside antibodies (Table) (2) (3) (4) (5) (6) . Four of these cases were combined with other cranial nerves and peripheral motor palsies, while only one case involved an asymmetrical and isolated hypoglossal nerve palsy. Anti-GM1 and antiGD1b IgG antibodies were detected in three of the five abovementioned cases, suggesting the major anti-ganglioside antibodies for hypoglossal nerve palsy. Anti-GD1a, antiGQ1b, anti-GD1b/GD1a and anti-GD1b/GT1b IgG antibodies were reported only in one case by Yamagami et al., but were still combined with anti-GD1b IgG antibodies.
The present patient with DLBCL showed a rare asymmetrical and isolated hypoglossal nerve palsy, and his serum was positive for anti-SPGM IgM antibodies as well as anti-GM1 and anti-GQ1b IgM antibodies. In patients with autoimmune neuropathy, anti-ganglioside IgM antibodies are associated with chronic disease, including malignant lymphoma, through the mechanism of 'binding site drift', while anti-ganglioside IgG antibodies are associated with acute diseases, including Guillain-Barré syndrome, through the mechanism of 'molecular mimicry' (7) . Some previously reported cases of autoimmune neuropathy in malignant lymphoma were associated with anti-ganglioside IgM antibod-ies, including anti-GM1, anti-GD1b, and anti-GQ1b IgM antibodies (1), while cases with M protein were accompanied by anti-SGPG IgM antibodies (8, 9) . Anti-GM1 IgM antibodies are related to an asymmetrical neuropathy, while anti-GQ1b and anti-SGPG IgM antibodies are usually associated with polyneuropathy (8, 9) ; one exception exists in a reported case of asymmetrical facial nerve palsy in a patient who was positive for anti-SGPG IgM antibodies (10) . Based on previous reports, the anti-GM1 and anti-SGPG IgM antibody positivity might have been associated with the asymmetrical and isolated hypoglossal nerve palsy in the present case. However, the anti-ganglioside IgM antibody activities were not analyzed at different clinical time points in the present case. Furthermore, the pathological mechanism through which anti-ganglioside IgM antibodies are associated with peripheral neuropathy in lymphoma has not been fully elucidated. Thus, an association between anti-ganglioside IgM antibodies and the isolated hypoglossal nerve palsy was suspected in the present case, but was not clearly confirmed.
In summary, we reported a very rare case of an asymmetrical and isolated hypoglossal nerve palsy that was accompanied by a new subset of anti-ganglioside antibodies associated with DLBCL. The present case might suggest that paraneoplastic syndrome with anti-ganglioside antibodies should be suspected in cases involving asymmetrical and isolated hypoglossal nerve palsy.
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